[Prematurity, progress and challenges]

Olivier Baud1

  • 1Inserm U1141,Université Paris-Diderot, Sorbonne Paris Cité,Service de réanimation et pédiatrie néonatales, Hôpital universitaire Robert-Debré, AP-HP, 48 boulevard Sérurier, 75019, Paris, France.

Insights

Premature birth remains a leading cause of infant mortality and long-term health issues. Advances in neonatal care, developmental support, and monitoring have improved survival and quality of life for premature infants.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Perinatology

Background:

  • Prematurity is a significant contributor to neonatal mortality and associated comorbidities.
  • Despite challenges, survival rates and quality of life for premature infants have improved.
  • Progress in neonatal care necessitates enhanced implementation of developmental care strategies.

Purpose of the Study:

  • To review the current landscape of neonatal care for premature infants.
  • To highlight advances in monitoring and developmental care.
  • To anticipate future innovations in perinatology.

Main Methods:

  • Literature review of recent advancements in neonatal care.
  • Analysis of trends in prematurity outcomes.
  • Synthesis of data on developmental care implementation.

Main Results:

  • Significant improvements in survival and quality of life for premature infants.
  • Notable progress in developmental care, with a need for better unit implementation.
  • Ongoing advancements in perinatology are expected.

Conclusions:

  • Neonatal care for premature infants has seen substantial progress.
  • Enhanced implementation of developmental care is crucial for optimizing outcomes.
  • Future innovations in perinatology hold promise for further improving care.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Planning Nursing Care I01:21

Planning Nursing Care I

The planning phase of the nursing process helps nurses set priorities, outline patient-centered goals and expected outcomes, and tailor nursing interventions to align with the aligned care plan. Through the planning phase, the nurse applies critical thinking skills to align and develop interventions according to the patient's needs. It provides continuity of care allowing patients to receive the maximum benefit from treatment. It serves as a pilot plan for allocating individual staff to a...
6.1K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.5K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
430